Position in NBIX
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$5,821,540
+$1,061,379 QoQ
Shares Held
34,541
-4.4% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#200
of 774 holders
Holding Since
Dec 2025
3 quarters on record
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Ruffer LLP holds $11,568,624 across 2 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (50.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
This page
|
34,541 | $5,821,540 | |
| 2 | ANIP |
Ani Pharmaceuticals Inc
|
69,426 | $5,747,084 |
All Filings in NBIX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,821,540 | 34,541 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $4,760,161 | 36,133 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,475,358 | 17,453 | Shares | Sole | 2026-01-28 | |
| No filing history on record for this holder in this stock. | ||||||